+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032- Product Image
Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032- Product Image
Sale

Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142986
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iodinated X-Ray Contrast Media Market is projected to reach USD 8.17 Billion in 2026. It is expected to continue growing at a CAGR of 10.28%, reaching USD 14.85 Billion by 2032.

Iodinated X-Ray Contrast Media: Executive Overview

Iodinated X-ray contrast media are diagnostic agents used to improve visualization during computed tomography, angiography, fluoroscopy, and other X-ray-based procedures. Demand is shaped by imaging volumes, cardiovascular and oncology care pathways, emergency diagnostics, hospital infrastructure, regulatory requirements, and the availability of low-osmolar and iso-osmolar formulations. Market development also depends on supply continuity, product quality, appropriate use, and clinical protocols that balance diagnostic value with renal, allergic, and other patient-safety considerations.

Imaging Modernization Is Reshaping Contrast-Media Use

The landscape is changing through wider adoption of advanced CT, image-guided intervention, cardiac imaging, and emergency-care workflows. Hospitals are placing greater emphasis on dose optimization, standardized injection protocols, renal-risk screening, allergy management, and rapid turnaround. Supply resilience has become a strategic concern because manufacturing complexity, specialized raw materials, quality controls, and concentrated production capacity can affect availability. Sustainability considerations are also gaining attention, including packaging, waste handling, water use, and responsible disposal of iodinated residues.

Artificial Intelligence Improves Protocol Selection and Workflow Control

Artificial intelligence is contributing to contrast-media workflows by supporting image reconstruction, protocol selection, patient-risk stratification, automated quality checks, and prioritization of urgent examinations. AI can help clinicians tailor scan parameters and contrast administration to anatomy, indication, renal function, and prior imaging, while reducing repeat examinations caused by suboptimal studies. Its benefits depend on representative training data, transparent validation, interoperability with radiology and hospital systems, human oversight, and safeguards against automation bias. AI does not remove the need for clinical judgment, informed consent, pharmacovigilance, or adherence to established safety procedures.

Regional Priorities Span Access, Safety, and Imaging Infrastructure

North America is characterized by extensive CT and interventional-imaging use, strong attention to protocol standardization, and active supply-continuity planning. Europe emphasizes clinical governance, patient safety, procurement discipline, and environmental considerations across diverse health systems. Asia-Pacific combines rapid imaging-capacity development with substantial variation in access, reimbursement, and hospital sophistication. Latin America is shaped by uneven distribution of advanced imaging, public-private system differences, and the need for dependable supply and training. The Middle East is investing in specialized hospitals and diagnostic infrastructure, while procurement, localization, and workforce development remain important. Africa faces the greatest variation in equipment availability, maintenance capacity, specialist staffing, and access to contrast-supported imaging, making resilient distribution and appropriate-use training central priorities.

Economic and Security Groups Reveal Different Adoption Conditions

ASEAN countries are balancing expanding diagnostic capacity with affordability, procurement coordination, and uneven specialist coverage. BRICS members reflect broad differences in domestic manufacturing, public-sector access, regulatory pathways, and healthcare investment. The European Union places importance on harmonized safety expectations, cross-border supply resilience, and sustainability requirements. G7 systems generally have mature imaging networks, established clinical guidance, and advanced data infrastructure, while still addressing cost control and aging populations. GCC countries are expanding high-acuity diagnostic and interventional services and often prioritize centralized procurement and technology modernization. NATO members span highly developed and more variable health systems, with continuity planning and medical logistics relevant to emergency preparedness.

Country Conditions Differ by Imaging Capacity and Health-System Design

Australia combines advanced imaging services with geographic access challenges and a focus on appropriate use. Brazil has substantial diagnostic demand alongside regional disparities between public and private provision. Canada’s system emphasizes centralized planning, access management, and rural service delivery. China is expanding imaging capacity while strengthening domestic supply resilience and regulatory oversight. France, Germany, Italy, and Spain operate mature European health systems with differing reimbursement, procurement, and hospital-governance models. India is experiencing broad diagnostic expansion but retains major urban-rural and public-private gaps. Japan and South Korea have sophisticated imaging ecosystems, strong quality expectations, and aging-population needs. Mexico is developing diagnostic infrastructure while addressing affordability and geographic variation. Russia’s environment is influenced by healthcare modernization, domestic production priorities, and procurement constraints. The United Kingdom emphasizes standardized clinical pathways, public-system efficiency, and service capacity. The United States has extensive advanced imaging use, decentralized purchasing, and strong focus on safety, supply continuity, and cost management.

Leadership Priorities: Build Resilience, Safety, and Evidence-Based Efficiency

Industry leaders should diversify qualified supply sources, strengthen contingency inventories, and maintain rigorous quality systems for active ingredients, finished products, packaging, and distribution. They should partner with hospitals to improve protocol standardization, renal-risk assessment, adverse-event reporting, and staff education. Product development should prioritize patient-specific dosing, compatibility with modern injectors, ease of administration, and reduced environmental burden without compromising diagnostic performance. Organizations adopting AI should establish clinical validation, monitoring, cybersecurity, data-governance, and override procedures. Strategic planning should also segment needs by public and private care, tertiary and community settings, and regions with limited imaging access, while aligning engagement with local regulatory and reimbursement requirements.

Methodology: Evidence-Based Assessment of Clinical and System Drivers

This executive summary uses a structured qualitative assessment of iodinated X-ray contrast media, examining clinical applications, imaging infrastructure, safety practices, technology adoption, supply-chain conditions, regulation, procurement, and healthcare-system characteristics. Regional, group, and country perspectives are integrated using publicly verifiable categories of evidence such as national health-policy documents, regulatory publications, professional clinical guidance, peer-reviewed literature, hospital-imaging practices, and documented infrastructure trends. The approach avoids unsupported numerical estimates and does not infer market size, share, or forecasts. Findings should be updated as regulations, clinical guidelines, manufacturing conditions, and diagnostic technologies evolve.

Conclusion: Sustainable Progress Requires Reliable Access and Responsible Innovation

Iodinated X-ray contrast media remain closely tied to the quality, reach, and efficiency of diagnostic imaging. Progress will depend less on product availability alone than on coordinated improvements in supply resilience, patient selection, protocol quality, workforce capability, infrastructure, and data-enabled workflow management. Regional and national conditions vary substantially, so leaders should combine global quality standards with locally appropriate access and procurement strategies. Responsible adoption of AI, stronger safety systems, and attention to environmental performance can support dependable diagnostic care while preserving clinical accountability.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iodinated X-Ray Contrast Media Market, by Product Type
7.1. Introduction
7.2. Ionic
7.3. Non Ionic
7.3.1. Dimeric Non Ionic
7.3.2. Monomeric Non Ionic
8. Iodinated X-Ray Contrast Media Market, by Osmolarity
8.1. Introduction
8.2. High Osmolar
8.3. Low Osmolar
8.3.1. Iso Osmolar
8.3.2. Low Medium Osmolar
9. Iodinated X-Ray Contrast Media Market, by Application
9.1. Introduction
9.2. Angiography
9.2.1. Cerebral Angiography
9.2.2. Coronary Angiography
9.2.3. Peripheral Angiography
9.3. Ct Imaging
9.3.1. Multi Detector Ct
9.3.2. Single Detector Ct
9.4. Urography
9.4.1. Intravenous Urography
9.4.2. Retrograde Urography
10. Iodinated X-Ray Contrast Media Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Centers
10.4.1. Imaging Centers
10.4.2. Radiology Laboratories
10.5. Hospitals
11. Iodinated X-Ray Contrast Media Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Iodinated X-Ray Contrast Media Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Iodinated X-Ray Contrast Media Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Arco Life Sciences Pvt. Ltd.
15.2. Bayer AG
15.3. Beijing Beilu Pharmaceutical Co., Ltd.
15.4. Berlex Laboratories, Inc.
15.5. Bracco Imaging S.p.A.
15.6. Fresenius Kabi AG
15.7. Fujifilm Holdings Corporation
15.8. GE Healthcare
15.9. Guerbet Group
15.10. Imax Pharmaceuticals Pvt. Ltd.
15.11. Iso-Tex Diagnostics, Inc.
15.12. JB Pharma Pvt. Ltd.
15.13. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
15.14. Jodas Expoim Pvt. Ltd.
15.15. Lantheus Medical Imaging, Inc.
15.16. Livealth Biopharma Pvt. Ltd.
15.17. Mallinckrodt Pharmaceuticals
15.18. Novalek Pharmaceuticals Pvt. Ltd.
15.19. S. N. Chemicals Pvt. Ltd.
15.20. Sagent Pharmaceuticals, Inc.
15.21. Sanochemia Pharmazeutika AG
15.22. Taejoon Pharm Co., Ltd.
15.23. Trivitron Healthcare Pvt. Ltd.
15.24. Unijules Life Sciences Limited
15.25. Unimark Remedies Limited
15.26. Venus Pharma Pvt. Ltd.
15.27. Vifor Pharma AG
15.28. Yangtze River Pharmaceutical Group Co., Ltd. (YRPG)
15.29. Zhejiang Starry Pharmaceutical Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iodinated X-Ray Contrast Media Market, Years Considered for the Study
FIGURE 2. Global Iodinated X-Ray Contrast Media Market, Research Design
FIGURE 3. Global Iodinated X-Ray Contrast Media Market, Research Framework
FIGURE 4. Global Iodinated X-Ray Contrast Media Market, Data Triangulation
FIGURE 5. Global Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2025 vs 2032 (%)
FIGURE 9. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iodinated X-Ray Contrast Media Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iodinated X-Ray Contrast Media Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iodinated X-Ray Contrast Media Market Segmentation & Coverage
TABLE 2. Global Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Ionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Non Ionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Non Ionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Non Ionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Dimeric Non Ionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Dimeric Non Ionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Dimeric Non Ionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Monomeric Non Ionic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Monomeric Non Ionic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Monomeric Non Ionic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 17. Global High Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global High Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global High Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Low Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Low Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Low Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Iso Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Iso Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Iso Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Low Medium Osmolar Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Low Medium Osmolar Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Low Medium Osmolar Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 30. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Cerebral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Cerebral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Cerebral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Coronary Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Coronary Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Coronary Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Peripheral Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Peripheral Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Peripheral Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Ct Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Ct Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Ct Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Multi Detector Ct Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Multi Detector Ct Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Multi Detector Ct Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Single Detector Ct Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Single Detector Ct Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Single Detector Ct Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Intravenous Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Intravenous Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Intravenous Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Retrograde Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Retrograde Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Retrograde Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Radiology Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Radiology Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Radiology Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 91. North America Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. North America Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 94. North America Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 95. North America Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 96. North America Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. North America Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 98. North America Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 99. North America Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 100. North America Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. North America Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 102. Latin America Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Latin America Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Latin America Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 105. Latin America Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 106. Latin America Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 107. Latin America Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Latin America Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 109. Latin America Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 110. Latin America Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 111. Latin America Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Latin America Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 113. Europe Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Europe Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. Europe Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 116. Europe Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 117. Europe Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 118. Europe Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Europe Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 120. Europe Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 121. Europe Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 122. Europe Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Europe Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 124. Middle East Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Middle East Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Middle East Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 127. Middle East Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 128. Middle East Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 129. Middle East Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Middle East Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 131. Middle East Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 132. Middle East Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 133. Middle East Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Middle East Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 135. Africa Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Africa Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Africa Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 138. Africa Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 139. Africa Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 140. Africa Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Africa Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 142. Africa Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 143. Africa Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 144. Africa Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Africa Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 146. Global Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. ASEAN Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. ASEAN Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 150. ASEAN Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 151. ASEAN Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 152. ASEAN Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. ASEAN Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 154. ASEAN Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 155. ASEAN Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 156. ASEAN Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. ASEAN Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 158. GCC Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. GCC Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. GCC Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 161. GCC Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 162. GCC Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 163. GCC Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. GCC Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 165. GCC Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 166. GCC Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 167. GCC Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. GCC Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 169. European Union Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. European Union Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. European Union Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 172. European Union Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 173. European Union Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 174. European Union Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. European Union Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 176. European Union Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 177. European Union Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 178. European Union Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. European Union Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 180. BRICS Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. BRICS Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. BRICS Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 183. BRICS Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 184. BRICS Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 185. BRICS Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. BRICS Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 187. BRICS Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 188. BRICS Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 189. BRICS Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. BRICS Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 191. G7 Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. G7 Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. G7 Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 194. G7 Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 195. G7 Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 196. G7 Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. G7 Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 198. G7 Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 199. G7 Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 200. G7 Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. G7 Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 202. NATO Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. NATO Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. NATO Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 205. NATO Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 206. NATO Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 207. NATO Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. NATO Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 209. NATO Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 210. NATO Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 211. NATO Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. NATO Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 213. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. United States Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 215. United States Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. United States Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 217. United States Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 218. United States Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 219. United States Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. United States Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 221. United States Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 222. United States Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 223. United States Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. United States Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 225. Canada Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 226. Canada Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Canada Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 228. Canada Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 229. Canada Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 230. Canada Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. Canada Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 232. Canada Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 233. Canada Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 234. Canada Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Canada Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 236. Mexico Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 237. Mexico Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Mexico Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 239. Mexico Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 240. Mexico Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 241. Mexico Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Mexico Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 243. Mexico Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 244. Mexico Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 245. Mexico Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Mexico Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 247. Brazil Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 248. Brazil Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. Brazil Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 250. Brazil Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 251. Brazil Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 252. Brazil Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Brazil Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 254. Brazil Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 255. Brazil Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 256. Brazil Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Brazil Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 258. United Kingdom Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 259. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 261. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 262. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 263. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 265. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 266. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 267. United Kingdom Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 269. Germany Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 270. Germany Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Germany Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 272. Germany Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 273. Germany Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 274. Germany Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Germany Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 276. Germany Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 277. Germany Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 278. Germany Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Germany Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 280. France Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 281. France Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. France Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 283. France Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 284. France Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 285. France Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. France Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 287. France Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 288. France Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 289. France Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. France Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 291. Russia Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 292. Russia Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 293. Russia Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 294. Russia Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 295. Russia Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 296. Russia Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Russia Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 298. Russia Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 299. Russia Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 300. Russia Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Russia Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 302. Italy Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 303. Italy Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. Italy Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 305. Italy Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 306. Italy Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 307. Italy Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Italy Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 309. Italy Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 310. Italy Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 311. Italy Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. Italy Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 313. Spain Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 314. Spain Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. Spain Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 316. Spain Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 317. Spain Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 318. Spain Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. Spain Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 320. Spain Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 321. Spain Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 322. Spain Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Spain Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 324. China Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 325. China Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 326. China Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
TABLE 327. China Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
TABLE 328. China Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
TABLE 329. China Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. China Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 331. China Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
TABLE 332. China Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
TABLE 333. China Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. China Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 335. India Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 336. India Iodinated X-Ray Contrast Media Market Size, by Product

Companies Mentioned

  • Arco Life Sciences Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Berlex Laboratories, Inc.
  • Bracco Imaging S.p.A.
  • Fresenius Kabi AG
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Guerbet Group
  • Imax Pharmaceuticals Pvt. Ltd.
  • Iso-Tex Diagnostics, Inc.
  • JB Pharma Pvt. Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • Livealth Biopharma Pvt. Ltd.
  • Mallinckrodt Pharmaceuticals
  • Novalek Pharmaceuticals Pvt. Ltd.
  • S. N. Chemicals Pvt. Ltd.
  • Sagent Pharmaceuticals, Inc.
  • Sanochemia Pharmazeutika AG
  • Taejoon Pharm Co., Ltd.
  • Trivitron Healthcare Pvt. Ltd.
  • Unijules Life Sciences Limited
  • Unimark Remedies Limited
  • Venus Pharma Pvt. Ltd.
  • Vifor Pharma AG
  • Yangtze River Pharmaceutical Group Co., Ltd. (YRPG)
  • Zhejiang Starry Pharmaceutical Co., Ltd.

Related Topics

Related Reports

X-ray Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

X-ray Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 167 Pages
  • Global
From
X-ray Angiography System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

X-ray Angiography System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 79 Pages
  • Global
From
Cylindrical Battery X-ray Imaging Inspection Market - Global Forecast 2026-2032 - Product Image

Cylindrical Battery X-ray Imaging Inspection Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Extraoral X-ray Films Market - Global Forecast 2026-2032 - Product Image

Extraoral X-ray Films Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
X-ray Mirror Lens Market - Global Strategic Business Report - Product Image

X-ray Mirror Lens Market - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.